Export 2757 results:
Author Title Type [ Year(Desc)]
1993
C. C. Gotay, Phillips, P. H., and Cheson, B. D., “Male-female differences in the impact of cancer therapy.”, Oncology (Williston Park), vol. 7, no. 2, pp. 67-74; discussion 74, 77, 1993.
D. E. Lilienfeld and Perl, D. P., “Projected neurodegenerative disease mortality in the United States, 1990-2040.”, Neuroepidemiology, vol. 12, no. 4, pp. 219-28, 1993.
1994
J. T. Warren and Dolatshahi, M., “Annual updated survey of worldwide HIV, SIV, and SHIV challenge studies in vaccinated nonhuman primates.”, J Med Primatol, vol. 23, no. 2-3, pp. 184-225, 1994.
D. E. Lilienfeld and Perl, D. P., “Projected neurodegenerative disease mortality among minorities in the United States, 1990-2040.”, Neuroepidemiology, vol. 13, no. 4, pp. 179-86, 1994.
1995
O. N, “Adjusting Moran’s I for population density,”, Stat Med, vol. 14, pp. 17-26, 1995.
N. Oden, “Adjusting Moran's I for population density.”, Stat Med, vol. 14, no. 1, pp. 17-26, 1995.
S. D, “Analysis of rejection outcomes and implications. A report of the North American Pediatric Renal Transplant Cooperative Study,”, Transplantation, vol. 59, pp. 500-504, 1995.
A. Tejani, Stablein, D., Alexander, S., Fine, R., and Harmon, W., “Analysis of rejection outcomes and implications--a report of the North American Pediatric Renal Transplant Cooperative Study.”, Transplantation, vol. 59, no. 4, pp. 500-4, 1995.
, “Analysis of the NAPRTCS Pediatric Dialysis Registry,”, Clinical Dialysis, vol. 43, pp. 938-43, 1995.
W. MC, “Case-cohort analysis of case-coverage studies of vaccine effectiveness,”, Am J Epidemiol, vol. 142, pp. 1000-6, 1995.
L. H. Moulton, Wolff, M. C., Brenneman, G., and Santosham, M., “Case-cohort analysis of case-coverage studies of vaccine effectiveness.”, Am J Epidemiol, vol. 142, no. 9, pp. 1000-6, 1995.
S. D. Sullivan EK, “Clinical co-relates of graft failure due to chronic rejection in North American children.”, 1995.
B. D. Cheson, Wilson, W. H., and Phillips, P. H., “Clinical trials at the medicine branch of the NCI-part 2.”, Oncology (Williston Park), vol. 9, no. 6, pp. 506, 509-10, 1995.
P. PH, “Clinical trials referral resource. Clinical trials at the Medicine Branch of the NCI-Part II,”, Oncology, vol. 9, pp. 506-9, 1995.
P. PH, “Clinical trials referral resource. Clinical trials at the Medicine Branch of the NCI-Part I,”, Oncology, vol. 9, pp. 292-4, 1995.
B. D. Cheson, Wittes, R. E., and Phillips, P. H., “Clinical trials Referral Resource. Clinical trials at the medicine branch of the NCI--Part I.”, Oncology (Williston Park), vol. 9, no. 4, pp. 292-4, 1995.
P. PH, “Clinical trials referral resource. Clinical trials at the Surgery Branch of the NCI-Part II,”, Oncology, vol. 9, pp. 453-5, 1995.
B. D. Cheson, Rosenberg, S. A., and Phillips, P. H., “Clinical trials referral resource. Clinical trials at the surgery branch of the NCI.”, Oncology (Williston Park), vol. 9, no. 5, pp. 453-4, 1995.
P. PH, “Clinical trials referral resource. Clinical trials of suramin,”, Oncology, vol. 9, pp. 161-3, 1995.
B. D. Cheson, Phillips, P. H., Pluda, J. M., and Christian, M., “Clinical trials referral resource. Clinical trials of suramin.”, Oncology (Williston Park), vol. 9, no. 2, p. 161, 163, 1995.
P. PH, “Clinical trials referral resource. Clinical trials with 9-aminocamptothecin,”, Oncology, vol. 9, pp. 7273-1, 1995.
“Clinical trials referral resource. Clinical trials with 9-aminocamptothecin.”, Oncology (Williston Park), vol. 9, no. 8, pp. 727-31, 1995.
P. PH, “Clinical trials referral resource. Mycosis fungoides/Sezary syndrome,”, Oncology, vol. 9, pp. 645-6, 1995.
B. D. Cheson, Foss, F. M., and Phillips, P. H., “Clinical Trials Referral Resource: Mycosis Fungoides/Sézary Syndrome.”, Oncology (Williston Park), vol. 9, no. 7, pp. 645-6, 1995.
P. PH, “Clinical trials referral resource. Myelodysplastic syndromes,”, Oncology, vol. 9, pp. 821-5, 1995.